Active Ingredient: ROFLUMILAST
Proprietary Name: ROFLUMILAST
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MCG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A208256
Product Number: 001
Approval Date: Sep 7, 2022
Applicant Holder Full Name: MSN LABORATORIES PRIVATE LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
